# China NMPA Drug Inspection - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. - Ibuprofen suspension

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shanghai-johnson-johnson-pharmaceutical-co-ltd/fc1f6c9a-d453-4b51-b7e5-acffd1c6c40a/
Source feed: China

> China NMPA drug inspection for Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Ibuprofen suspension. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Shanghai Johnson & Johnson Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen suspension
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/shanghai-johnson-johnson-pharmaceutical-co-ltd/9a924e53-b031-4987-b0e4-6d45494d6e61/